86,339 Shares in Agilent Technologies, Inc. $A Acquired by Mirae Asset Global Investments Co. Ltd.

Mirae Asset Global Investments Co. Ltd. purchased a new stake in shares of Agilent Technologies, Inc. (NYSE:A) in the third quarter, according to its most recent disclosure with the SEC. The firm purchased 86,339 shares of the medical research company’s stock, valued at approximately $14,877,000.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Bank of New York Mellon Corp increased its stake in Agilent Technologies by 87.4% in the 2nd quarter. Bank of New York Mellon Corp now owns 5,233,964 shares of the medical research company’s stock worth $695,227,000 after purchasing an additional 2,440,360 shares in the last quarter. Legal & General Group Plc acquired a new stake in Agilent Technologies during the 2nd quarter worth about $260,101,000. Bank of America Corp DE purchased a new stake in Agilent Technologies during the second quarter valued at about $213,269,000. Man Group plc acquired a new position in shares of Agilent Technologies in the second quarter worth about $179,257,000. Finally, Primecap Management Co. CA acquired a new position in shares of Agilent Technologies in the second quarter worth about $176,318,000.

Agilent Technologies Stock Performance

A opened at $175.73 on Wednesday. The firm has a market capitalization of $49.54 billion, a P/E ratio of 34.59, a price-to-earnings-growth ratio of 2.52 and a beta of 1.24. The stock’s 50 day moving average price is $164.81 and its two-hundred day moving average price is $136.68. The company has a quick ratio of 1.56, a current ratio of 2.05 and a debt-to-equity ratio of 0.50. Agilent Technologies, Inc. has a 12-month low of $108.35 and a 12-month high of $182.99.

Agilent Technologies (NYSE:A) last released its earnings results on Wednesday, August 26th. The medical research company reported $1.62 earnings per share for the quarter, beating the consensus estimate of $1.49 by $0.13. The business had revenue of $1.88 billion during the quarter, compared to analysts’ expectations of $1.84 billion. Agilent Technologies had a net margin of 19.53% and a return on equity of 24.45%. The firm’s revenue was up 8.1% on a year-over-year basis. During the same quarter last year, the company earned $1.37 earnings per share. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. On average, equities analysts forecast that Agilent Technologies, Inc. will post 6.20 earnings per share for the current year.

Agilent Technologies Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, October 28th. Investors of record on Tuesday, October 6th were given a $0.2550 dividend. This represents a $1.02 annualized dividend and a yield of 0.6%. The ex-dividend date of this dividend was Tuesday, October 6th. Agilent Technologies’s dividend payout ratio is 20.08%.

Analyst Upgrades and Downgrades

Several brokerages have issued reports on A. Barclays boosted their target price on shares of Agilent Technologies from $175.00 to $195.00 and gave the company an “overweight” rating in a research note on Wednesday, October 7th. Piper Sandler raised their target price on Agilent Technologies from $150.00 to $160.00 and gave the stock a “neutral” rating in a research report on Friday, August 28th. Sanford C. Bernstein lifted their price target on Agilent Technologies from $155.00 to $180.00 and gave the company an “outperform” rating in a report on Thursday, August 27th. Stifel Nicolaus lifted their price target on Agilent Technologies from $170.00 to $180.00 and gave the company a “buy” rating in a report on Thursday, August 27th. Finally, Jefferies Financial Group started coverage on Agilent Technologies in a research report on Thursday, July 9th. They set a “hold” rating and a $135.00 price target on the stock. Eighteen investment analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. According to data from MarketBeat, Agilent Technologies has an average rating of “Moderate Buy” and a consensus target price of $181.45.

Insider Buying and Selling

In other Agilent Technologies news, Director Mikael Dolsten sold 634 shares of the firm’s stock in a transaction dated Friday, September 4th. The shares were sold at an average price of $151.38, for a total transaction of $95,974.92. Following the completion of the transaction, the director owned 4,924 shares in the company, valued at $745,395.12. This trade represents a 11.41% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Agilent Technologies Company Profile

Agilent Technologies, Inc is a global provider of analytical laboratory instruments, software, services and consumables. The company serves customers in the pharmaceutical, biotechnology, chemical, food, environmental, energy and academic research sectors, as well as diagnostic and clinical laboratories.

Agilent’s offerings include liquid and gas chromatography systems, mass spectrometry instruments, spectroscopy and atomic instruments, laboratory automation products, genomic and cell analysis solutions, and related software.